CW
Read verified employer references
Subscribe to access full references, ratings and rehire decisions.
Career Highlights
Awards & Recognition
★Successfully led transformation of 240+ year old Japanese pharmaceutical company as first foreign CEO
★Orchestrated one of largest pharmaceutical mergers in history ($62B Shire acquisition)
★Recognized as one of longest-tenured CEOs in pharmaceutical industry
Notable Facts
→First foreign CEO of Takeda Pharmaceutical, Japan's oldest pharmaceutical company (founded 1781)
→Led $62 billion acquisition of Shire in 2019, one of largest pharma deals in history
→Member of World Economic Forum's International Business Council and NYSE Board Advisory Council
→Serves on MIT CEO Advisory Board and Northeastern University Board of Trustees
→Lives in both Tokyo and Boston, fluent in multiple markets
→20+ years at GlaxoSmithKline before joining Takeda in 2014
→Holds doctorate in pharmacy and pharmacokinetics from University of Lyon
→Announced retirement in 2025, successor Julie Kim appointed for June 2026
Employer References
Badges
Press Favourite
Award Cabinet
Speaker Circuit
Global VoiceOnline Presence